期刊文献+

抑癌基因p53突变与肝细胞癌预后的关系 被引量:3

The relationship between mutation of suppressor gene p53 and prognosis of hepatocellular carcinoma.
原文传递
导出
摘要 目的探讨抑癌基因p53突变与肝细胞癌(HCC)预后的关系。方法采用聚合酶链反应-限制性片段长度多态性分析技术,检测HCC p53基因第7外显子点突变,研究55例来自南宁地区的HCC。结果 34例HCC p53基因249密码子发生点突变,伴HCC转移者16例,未转移者18例;Ⅰ级分化1例,Ⅱ~Ⅲ级15例,Ⅳ级18例。p53基因突变型的HCC病人与非突变型的HCC病人1年、3年和5年生存率两两比较有显著性差异(P<0.05)。结论 p53基因突变与HCC的恶性程度及预后有关。 Objective To study the relationship between mutation of suppressor gene p53 and prognosis of hepatocellular carcinoma (HCC). Methods Fifty-five cases of HCC from Naning prefecture were studied by combined use of polymerase chain reaction and restrictive fragment length polymorphism analysis to examine the exon 7 of p53 gene in HCC. Results In 55 cases of HCC,mutation at codon 249 of p53 gene was found in 34 cases with metastassi in 16 cases and without metastasis in 18. The total of p53 gene mutation was 1,15, and 18 cases in stage Ⅰ, stages Ⅱ - Ⅲ , and stage Ⅳ differentiated HCC, respectively. The 1-year, 3-year, and 5-year survival rates of the patients with mutation of p53 gene versus the group of those with no mutation showed statistically significant difference respectively (P<0.05). Conclusion p53 gene mutation is correlated wish the malignant degree and prognosis of HCC.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 1998年第4期316-317,共2页 Chinese Journal of Experimental Surgery
关键词 肝肿瘤 肝细胞癌 P53基因 基因突变 Hepatocellular carcinoma p53 gene Polymerase chain reaction Prognosis
  • 相关文献

参考文献2

  • 1刘启福,癌症,1994年,13卷,365页
  • 2赵坡,中华病理学杂志,1993年,22卷,16页

同被引文献22

  • 1蔡德巍,高长泽,王能进.c-myc基因和p53蛋白在肝细胞癌中的表达[J].中华病理学杂志,1994,23(2):100-103. 被引量:21
  • 2Lukas J, Groshen S, Saffari B, et el. WAFI/CIPI gene polymorphysim and expression in carcinomas of the breast, ovary and endometrium. Am J Pathol, 1997;150( 1 ) : 167 -75.
  • 3Hui AM, Kanai Y, Sakamoto M, et al. Reduced p21 WAF1/CIP1 expression and p53 mutation in hepatoeellular careinomas[J].Hepatology, 1997 ; 25 : 575 - 579.
  • 4Furutani M, Arii S, Tanaja H, et al. Decreased expression and rare somatic mutation of the CIP1/WAF1 gene in human hepatocellular carcinoma. Cancer Lett, 1997 ; 111 : 191.
  • 5Haupt Y, Maya R, Kazaz A, et al. MDM2 promotes the rapid degradation of p53[J]. Nature, 1997;387:296-299.
  • 6Momand J, Zambetti GP, Olson DC, et al. The mdm2 oncogene products forms a complex with the p53 protein and inhibits p53 mediated transactivation[J]. Cell, 1992;69:1237-1245.
  • 7Oliner JD, Pietenpol JA, Thiagalingan S, et al. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53[J].Nature, 1993;362:857-860.
  • 8Skomedal H, Kristensen GB, Abeler VA, et al. TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumors and stage 1 carcinomas[J].J Pathol 1997; 181 : 158 - 165.
  • 9Wakasugi E, Kobaigashi T, Tamaki T, et al, p21 (WAF1/CIP1)and p53 protein expression in breast cancer.Am J Clin Pathol,1997; 107(6) :684--691.
  • 10Zolota V, Batistatou A, Tsamandas A, et al. Immunohistochemical Expression of TGF- betal, p21WAFI, p53, Ki67, and Angiogenesis in Gastric Carcinomas: A Clinicopathologic Study. Int J Gastrointest Cancer, 2003; 32 (2 - 3) : 83 - 90.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部